"Psoriasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
Descriptor ID |
D011565
|
MeSH Number(s) |
C17.800.859.675
|
Concept/Terms |
Pustulosis of Palms and Soles- Pustulosis of Palms and Soles
- Pustulosis Palmaris et Plantaris
- Palmoplantaris Pustulosis
- Pustular Psoriasis of Palms and Soles
|
Below are MeSH descriptors whose meaning is more general than "Psoriasis".
Below are MeSH descriptors whose meaning is more specific than "Psoriasis".
This graph shows the total number of publications written about "Psoriasis" by people in this website by year, and whether "Psoriasis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 0 | 4 |
1995 | 1 | 0 | 1 |
1996 | 5 | 1 | 6 |
1997 | 3 | 1 | 4 |
1998 | 5 | 1 | 6 |
1999 | 1 | 0 | 1 |
2000 | 2 | 1 | 3 |
2001 | 1 | 1 | 2 |
2003 | 2 | 1 | 3 |
2004 | 4 | 0 | 4 |
2005 | 6 | 0 | 6 |
2006 | 3 | 1 | 4 |
2007 | 2 | 1 | 3 |
2008 | 2 | 1 | 3 |
2009 | 2 | 0 | 2 |
2010 | 3 | 1 | 4 |
2011 | 3 | 0 | 3 |
2012 | 0 | 1 | 1 |
2013 | 2 | 0 | 2 |
2014 | 2 | 0 | 2 |
2015 | 3 | 1 | 4 |
2016 | 0 | 1 | 1 |
2018 | 1 | 3 | 4 |
2019 | 4 | 0 | 4 |
2020 | 0 | 1 | 1 |
2021 | 2 | 1 | 3 |
2022 | 1 | 0 | 1 |
2023 | 2 | 0 | 2 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Psoriasis" by people in Profiles.
-
Revolutionizing Psoriasis Topical Treatment: Enhanced Efficacy Through Ceramide/Phospholipid Composite Cerosomes Co-Delivery of Cyclosporine and Dithranol: In-Vitro, Ex-Vivo, and in-Vivo Studies. Int J Nanomedicine. 2024; 19:1163-1187.
-
Histological and functional characterization of 3D human skin models mimicking the inflammatory skin diseases psoriasis and atopic dermatitis. Dis Model Mech. 2024 Jan 01; 17(1).
-
Obstructive sleep apnea among patients with psoriasis: A case-control study in the All of Us Research Program. J Am Acad Dermatol. 2024 Mar; 90(3):666-668.
-
IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis. J Invest Dermatol. 2023 09; 143(9):1689-1699.
-
Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk. Int J Cancer. 2022 Dec 15; 151(12):2155-2160.
-
Severe de novo pustular psoriasiform immune-related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma. J Cutan Pathol. 2022 May; 49(5):472-481.
-
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients. J Eur Acad Dermatol Venereol. 2022 Mar; 36(3):e233-e235.
-
Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and joints. Rheumatology (Oxford). 2021 10 19; 60(Suppl 4):iv16-iv27.
-
A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist. J Med Chem. 2020 05 14; 63(9):4776-4789.
-
Discovery of IgG4 Anti-Gliadin Autoantibody as a Potential Biomarker of Psoriasis Using an Autoantigen Array. Proteomics Clin Appl. 2020 03; 14(2):e1800114.